Hugo Wurtele
Has grant
Full Professor (Professeur titulaire)
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Open
Impact of Ikaros isoforms on coordinating transcriptional elongation and co-transcriptional RNA processing — Co-Applicant
Open Date: 2026-09-01
Close Date: 2028-08-01
Grant: Open
Understanding and targeting single-stranded DNA gap-filling mechanisms to improve the impact of chemotherapy — Co-Applicant
Open Date: 2025-09-01
Close Date: 2027-08-01
Grant: Open
Nascent chromatin structure and the cellular response to DNA replication stress — Principal Investigator
Open Date: 2025-04-01
Close Date: 2030-03-01
Grant: Open
Single-stranded DNA generation during UV-induced replicative stress in skin cancer — Principal Investigator
Open Date: 2024-10-01
Close Date: 2029-10-01
Grant: Close
A novel role for oncogenic cyclin D1 in nucleotide excision repair — Co-Applicant
Open Date: 2023-09-01
Close Date: 2025-09-01
Articles (4)
Year:
2026
Year:
2026
Acute myeloid leukemia (AML) with rearrangement of the mixed lineage leukemia gene expresses MLL-AF9 fusion protein, a transcription factor that impairs differentiation and drives expansion of leukemic cells. In this work, the zinc finger protein “growth factor independent 1” together with the histone methyltransferase LSD1 is revealed to occupy the promoter and regulate the expression of the lncRNA ELDR (EGFR [epidermal growth factor receptor] long non-coding downstream RNA) in the rearranged Mixed Lineage Leukemia (MLL) (MLL-r) AML cell line THP-1. Forced ELDR overexpression enhanced the growth inhibition of an Lysine-Specific Demethylase 1 inhibitor (LSD1i)/all-trans retinoic acid (ATRA) combination treatment and reduced the capacity of these cells to generate leukemia in xenografts, leading to a longer leukemia-free survival. ELDR is found to bind the clamp protein Proliferating Cell Nuclear Antigen (PCNA) and the MCM5 helicases causing defects of DNA replication fork progression. Moreover, AML cells overexpressing ELDR had reduced chromatin accessibility and transcription at α-satellite repeats in centromeres. In addition, ELDR RNA was detected close to MLL-AF9 at centromeres suggesting that it impedes leukemic progression preferentially of MLL-r AML by interfering with both DNA replication and centromeric transcription. Our findings reveal novel functions of the lncRNA ELDR in DNA replication and centromere biology when expressed at high levels in AML cells with MLL rearrangements. These discoveries could provide rationale for future strategies to treat MLL-r AML, which has a poor prognosis in children and adults. Delivery of the ELDR RNA could potentially be used as an adjunct to LSD1i/ATRA treatment or other currently used chemotherapeutic drugs to develop novel therapies for these AML subtypes.
Year:
2025
DNA fiber assays are powerful tools for investigating replication dynamics at the single-molecule level. However, their application and widespread adoption has been hampered by the labor-intensive and tedious nature of manual analysis of large numbers of images. Quantification of labeled DNA fibers typically depends on subjective examination, selection, and annotation of individual fibers from fluorescence microscopy images reducing inter-user consistency, reproducibility, and experimental throughput. To address these issues, we developed DNAi, a computer vision tool based on deep learning allowing automated detection and quantification of labeled DNA fiber length. DNAi was trained on a large and diverse dataset of manually annotated images of DNA fibers and matches human performance and accuracy in segmentation and length measurement across a wide range of experimental conditions. The open-source tool includes a user-friendly interface, which permits visual validation and manual selection of segmented fibers. Overall, DNAi enables robust, rapid, and reproducible DNA fiber analysis, and is freely available. Graphical abstract
Year:
2025
Collaborators (4)
Santiago Costantino
Chercheur
Université de Montréal
Julie Ross
Institut de recherches cliniques de Montréal
Virginie Calderon
Institut de recherches cliniques de Montréal
Renaud Duval
Université de Montréal
Make your next move.
Prepare your application
Review drafts before you send them.